KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd 
(MGRC) has signed a series of collaborations to grow its customer base in Thailand, as well as explore opportunities for research and development (R& D) of new products and services.
In a filing with Bursa Malaysia, the genomics and biopharmaceutical specialist said it had signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development Co Ltd to produce CAR T-cells for supply to Acquest’s customers.
It also signed a supply and collaboration agreement with Salus Holdings Co Ltd to supply biopharmaceutical and genomics products and services to Salus’ customers.
Salus is a specialist in wellness and health screening using science and technology for early disease detection and managing programmes for
lifestyle intervention based in Bangkok, Thailand.
Finally, the group signed a letter of intent with Marine Group Co Ltd and Salus on collaborative research in the use of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients on the regeneration of skin and hair of patients.
“We are looking forward to a fruitful relationship with our Thai partners, Salus and Acquest. These collaborations are part of all of our strategy of increasing our customer base and also increasing our reputation overseas through making use of business partners diagnosed with an established presence inside their respective market clips, ” MGRC chief executive officer Sasha Nordin talked about.